blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1382333

EP1382333 - Use of beta 3 adrenergic receptor agonists in the treatment of dysuria [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.01.2010
Database last updated on 07.10.2024
Most recent event   Tooltip22.04.2011Lapse of the patent in a contracting state
New state(s): LU		published on 25.05.2011  [2011/21]
Applicant(s)For all designated states
Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo / JP
[2006/01]
Former [2004/04]For all designated states
FUJISAWA PHARMACEUTICAL CO., LTD.
4-7, Doshomachi 3-chome Chuo-ku
Osaka-shi Osaka 541-8514 / JP
Inventor(s)01 / Taniguchi, Kiyoshi
2-1-28, Minamiochiai Suma-ku
Kobe-shi Hyogo 654-0153 / JP
02 / Sakurai, Minoru
2-18-1-A206, Haradamotomachi
Toyonaka-shi Osaka 561-0808 / JP
03 / Fujii, Naoaki
15-1-221, Tonomachi
Takatsuki-shi Osaka 569-1126 / JP
04 / Hosoi, Kumi
91-2-A305. Futatsuya
Susono-shi Shizuoka 410-1128 / JP
05 / Tomishima, Yasuyo
2-2-1-1420, Ohgi Higashinada-ku
Kobe-shi Hyogo 658-0027 / JP
06 / Takasugi, Hisashi
3-116-10, Mozu Umekitacho
Sakai-shi Osaka 591-8031 / JP
07 / Sogabe, Hajime
3-10-21-102, Daidou Higashiyodogawa-ku
Osaka-shi Osaka 533-0011 / JP
08 / Ishikawa, Hirofumi
27-E-502, Shinashiyakami
Suita-shi Osaka 565-0804 / JP
09 / Hanioka, Naomi
2-12-12-A908, Nishijyuku
Minoo-shi Osaka 562-0034 / JP
 [2004/04]
Representative(s)Gille Hrabal Partnerschaftsgesellschaft mbB Patentanwälte
Brucknerstraße 20
40593 Düsseldorf / DE
[N/P]
Former [2008/40]Gille Hrabal Struck Neidlein Prop Roos
Patentanwälte Brucknerstrasse 20
40593 Düsseldorf / DE
Former [2004/04]Gille Hrabal Struck Neidlein Prop Roos
Patentanwälte, Brucknerstrasse 20
40593 Düsseldorf / DE
Application number, filing date03021612.125.03.1999
[2004/04]
Priority number, dateAU1998PP0282606.04.1998         Original published format: AU PP282698
AU1998PP0505804.08.1998         Original published format: AU PP505898
[2004/04]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1382333
Date:21.01.2004
Language:EN
[2004/04]
Type: A3 Search report 
No.:EP1382333
Date:04.02.2004
[2004/06]
Type: B1 Patent specification 
No.:EP1382333
Date:25.02.2009
Language:EN
[2009/09]
Search report(s)(Supplementary) European search report - dispatched on:EP18.12.2003
ClassificationIPC:A61K31/165, A61K31/223, A61K31/404, A61K31/4045, A61K31/426, A61K31/44, A61K31/4402, A61K31/4406, A61K31/4409, A61K31/4468, A61K31/495, A61K31/501, A61K31/5375, A61P13/02
[2004/04]
CPC:
C07D213/40 (EP,US); A61K31/165 (EP,US); A61K31/223 (EP,US);
A61K31/404 (EP,US); A61K31/4045 (EP,US); A61K31/426 (EP,US);
A61K31/44 (EP,US); A61K31/4402 (EP,US); A61K31/4406 (EP,US);
A61K31/4409 (EP,US); A61K31/4468 (EP,US); A61K31/495 (EP,US);
A61K31/501 (EP,US); A61K31/5375 (EP,US); A61P1/00 (EP);
A61P1/04 (EP); A61P13/00 (EP); A61P13/02 (EP);
A61P3/06 (EP); A61P43/00 (EP); C07C215/46 (EP,US);
C07C217/30 (EP,US); C07C217/74 (EP,US); C07C219/24 (EP,US);
C07C229/18 (EP,US); C07C229/50 (EP,US); C07C233/25 (EP,US);
C07C233/43 (EP,US); C07C233/80 (EP,US); C07C235/20 (EP,US);
C07C235/24 (EP,US); C07C237/48 (EP,US); C07C271/24 (EP,US);
C07C271/30 (EP,US); C07C271/58 (EP,US); C07C275/22 (EP,US);
C07C279/22 (EP,US); C07C307/02 (EP,US); C07C307/10 (EP,US);
C07C311/08 (EP,US); C07C311/18 (EP,US); C07C317/32 (EP,US);
C07C323/25 (EP,US); C07C323/41 (EP,US); C07D209/08 (EP,US);
C07D209/16 (EP,US); C07D211/26 (EP,US); C07D213/73 (EP,US);
C07D213/85 (EP,US); C07D233/60 (EP,US); C07D235/26 (EP,US);
C07D277/46 (EP,US); C07D295/185 (EP,US); C07D401/04 (EP,US);
C07D417/14 (EP,US); C07C2601/06 (EP,US); C07C2601/14 (EP,US);
C07C2602/12 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2004/04]
TitleGerman:Verwendung von beta-3-adrenergen-Rezeptoren Agonisten in der Behandlung von Dysurie[2004/04]
English:Use of beta 3 adrenergic receptor agonists in the treatment of dysuria[2004/04]
French:Emploi d'agonistes des récepteurs adrénergiques béta 3 dans le traitement de la dysurie[2008/38]
Former [2004/04]Emploi d'agonistes des récepteurs adrergéniques beta 3 dans le traitement de la dysurie
Examination procedure28.07.2004Examination requested  [2004/40]
25.07.2005Despatch of a communication from the examining division (Time limit: M08)
12.05.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
13.07.2006Reply to a communication from the examining division
25.01.2007Despatch of a communication from the examining division (Time limit: M06)
26.07.2007Reply to a communication from the examining division
18.09.2008Communication of intention to grant the patent
15.12.2008Fee for grant paid
15.12.2008Fee for publishing/printing paid
Parent application(s)   TooltipEP99909333.9  / EP1070046
Opposition(s)26.11.2009No opposition filed within time limit [2010/05]
Request for further processing for:13.07.2006Request for further processing filed
12.07.2006Full payment received (date of receipt of payment)
Request granted
26.07.2006Decision despatched
Fees paidRenewal fee
17.10.2003Renewal fee patent year 03
17.10.2003Renewal fee patent year 04
17.10.2003Renewal fee patent year 05
15.03.2004Renewal fee patent year 06
14.03.2005Renewal fee patent year 07
09.03.2006Renewal fee patent year 08
14.03.2007Renewal fee patent year 09
14.03.2008Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT25.02.2009
BE25.02.2009
DK25.02.2009
FI25.02.2009
IT25.02.2009
NL25.02.2009
IE25.03.2009
LU25.03.2009
CH31.03.2009
LI31.03.2009
SE25.05.2009
GR26.05.2009
ES05.06.2009
PT12.08.2009
[2011/21]
Former [2011/14]AT25.02.2009
BE25.02.2009
DK25.02.2009
FI25.02.2009
IT25.02.2009
NL25.02.2009
IE25.03.2009
CH31.03.2009
LI31.03.2009
SE25.05.2009
GR26.05.2009
ES05.06.2009
PT12.08.2009
Former [2010/48]AT25.02.2009
BE25.02.2009
DK25.02.2009
FI25.02.2009
NL25.02.2009
IE25.03.2009
CH31.03.2009
LI31.03.2009
SE25.05.2009
GR26.05.2009
ES05.06.2009
PT12.08.2009
Former [2010/08]AT25.02.2009
BE25.02.2009
DK25.02.2009
FI25.02.2009
NL25.02.2009
IE25.03.2009
CH31.03.2009
LI31.03.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
Former [2010/07]AT25.02.2009
BE25.02.2009
DK25.02.2009
FI25.02.2009
NL25.02.2009
IE25.03.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
Former [2009/49]AT25.02.2009
BE25.02.2009
DK25.02.2009
FI25.02.2009
NL25.02.2009
SE25.05.2009
ES05.06.2009
PT12.08.2009
Former [2009/46]AT25.02.2009
BE25.02.2009
DK25.02.2009
FI25.02.2009
NL25.02.2009
SE25.05.2009
ES05.06.2009
Former [2009/43]AT25.02.2009
BE25.02.2009
FI25.02.2009
NL25.02.2009
SE25.05.2009
Former [2009/40]AT25.02.2009
FI25.02.2009
NL25.02.2009
SE25.05.2009
Former [2009/38]FI25.02.2009
NL25.02.2009
SE25.05.2009
Former [2009/34]NL25.02.2009
Documents cited:Search[DY]EP0023385  (BEECHAM GROUP PLC [GB]) [DY] 1,5,7-10 * abstract *;
 [DY]EP0211721  (SANOFI SA [FR], et al) [DY] 1,4,7-10 * abstract *;
 [DY]EP0659737  (BRISTOL MYERS SQUIBB CO [US]) [DY] 1,2,7-10 * abstract *;
 [DY]US5561142  (FISHER MICHAEL H [US], et al) [DY] 1,3,7-10 * abstract * * claim 1 *;
 [Y]WO9715549  (TOKYO TANABE CO [JP], et al) [Y] 1-10;
 [DY]WO9725311  (ASAHI CHEMICAL IND [JP], et al)[DY] 1,6-10;
 [PLY]EP0882707  (ASAHI CHEMICAL IND [JP]) [PLY] 1,6-10 * abstract *;
 [PLY]EP0940387  (TOKYO TANABE CO [JP]) [PLY] 1-10 * abstract * * paragraph [0007] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.